<DOC>
	<DOCNO>NCT00518622</DOCNO>
	<brief_summary>The purpose study investigate effectiveness , safety , tolerability MK7009 patient infect Hepatitis C</brief_summary>
	<brief_title>Study Safety Effectiveness MK7009 Hepatitis C Infected Patients ( MK-7009-004 ) ( COMPLETED )</brief_title>
	<detailed_description />
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis A</mesh_term>
	<mesh_term>Hepatitis C</mesh_term>
	<criteria>Subject man woman age 18 55 year age . Subject chronic Hepatitis C Subject willing use alcohol 2 week prior therapy study followup period Patient evidence advance liver disease . Patient human immunodeficiency virus ( HIV ) Patient Hepatitis B</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>August 2015</verification_date>
</DOC>